US Patent Issued to Koranex Capital on July 28 for "Synthetic glycolipids and glycoliposome compositions : suitable for cargo delivery to the central nervous system" (Canadian, French Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,069, issued on July 28, was assigned to Koranex Capital (Montreal).

"Synthetic glycolipids and glycoliposome compositions : suitable for cargo delivery to the central nervous system" was invented by Tze Chieh Shiao (Montreal), Serge Mignani (Chatenay-Malabry, France) and Rene Roy (Terrebonne, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to synthetic glycolipids of the formula (I): wherein * A represents (CH2)n with n being an integer from 2 to 10 or CH2-CH2-[O-CH2-CH2]m with m being an integer from 1 to 5; * B represents NR3 or OCH2, with R3 representing H, Me, Et or n-Pr; * "Sugar" represents formulas (A) or ...